Sandrine Vendeville

1.2k total citations
15 papers, 519 citations indexed

About

Sandrine Vendeville is a scholar working on Molecular Biology, Epidemiology and Hepatology. According to data from OpenAlex, Sandrine Vendeville has authored 15 papers receiving a total of 519 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Molecular Biology, 7 papers in Epidemiology and 7 papers in Hepatology. Recurrent topics in Sandrine Vendeville's work include Hepatitis C virus research (7 papers), Hepatitis B Virus Studies (5 papers) and HIV/AIDS drug development and treatment (4 papers). Sandrine Vendeville is often cited by papers focused on Hepatitis C virus research (7 papers), Hepatitis B Virus Studies (5 papers) and HIV/AIDS drug development and treatment (4 papers). Sandrine Vendeville collaborates with scholars based in France, United States and Belgium. Sandrine Vendeville's co-authors include Pierre Raboisson, Maxwell D. Cummings, Christian Sergheraert, Oliver Lenz, Kenny Simmen, Herman de Kock, Åsa Rosenquist, Bertil Samuelsson, Magnus Nilsson and Elisabeth Davioud–Charvet and has published in prestigious journals such as Journal of Biological Chemistry, Hepatology and Journal of Virology.

In The Last Decade

Sandrine Vendeville

15 papers receiving 508 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Sandrine Vendeville France 11 195 184 174 144 135 15 519
Bryan D. Cox United States 15 171 0.9× 230 1.3× 49 0.3× 163 1.1× 91 0.7× 31 578
Christine Burlein United States 11 98 0.5× 184 1.0× 144 0.8× 182 1.3× 107 0.8× 18 449
S. Benzaria France 11 183 0.9× 335 1.8× 139 0.8× 370 2.6× 171 1.3× 25 638
John Pichardo United States 15 120 0.6× 163 0.9× 153 0.9× 146 1.0× 205 1.5× 30 458
Debra Montgomery United States 18 240 1.2× 384 2.1× 250 1.4× 185 1.3× 106 0.8× 31 820
Jayakanth Kankanala United States 19 191 1.0× 365 2.0× 303 1.7× 302 2.1× 55 0.4× 30 863
Alessia Petrocchi Italy 11 92 0.5× 298 1.6× 138 0.8× 258 1.8× 114 0.8× 18 561
Stefania Colarusso Italy 12 144 0.7× 184 1.0× 218 1.3× 174 1.2× 295 2.2× 16 619
Jimmy Lindberg Sweden 14 202 1.0× 370 2.0× 220 1.3× 315 2.2× 233 1.7× 24 844
Jeff A. O’Meara Canada 14 95 0.5× 225 1.2× 261 1.5× 94 0.7× 39 0.3× 21 587

Countries citing papers authored by Sandrine Vendeville

Since Specialization
Citations

This map shows the geographic impact of Sandrine Vendeville's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sandrine Vendeville with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sandrine Vendeville more than expected).

Fields of papers citing papers by Sandrine Vendeville

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sandrine Vendeville. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sandrine Vendeville. The network helps show where Sandrine Vendeville may publish in the future.

Co-authorship network of co-authors of Sandrine Vendeville

This figure shows the co-authorship network connecting the top 25 collaborators of Sandrine Vendeville. A scholar is included among the top collaborators of Sandrine Vendeville based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sandrine Vendeville. Sandrine Vendeville is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

15 of 15 papers shown
1.
Vanrusselt, Hannah, Dieudonné Buh Kum, Valério Taverniti, et al.. (2023). Novel non-HAP class A HBV capsid assembly modulators have distinct in vitro and in vivo profiles. Journal of Virology. 97(10). e0072223–e0072223. 4 indexed citations
2.
Kum, Dieudonné Buh, Hannah Vanrusselt, Valério Taverniti, et al.. (2023). Class A capsid assembly modulator RG7907 clears HBV-infected hepatocytes through core-dependent hepatocyte death and proliferation. Hepatology. 78(4). 1252–1265. 14 indexed citations
4.
Zhang, Qingling, Sandrine Vendeville, V. N. Serebryany, et al.. (2020). ALG-000184, a prodrug of capsid assembly modulator ALG-001075, demonstrates best-in-class preclinical characteristics for the treatment of chronic hepatitis B. Journal of Hepatology. 73. S880–S881. 4 indexed citations
5.
Roymans, Dirk, Sandrine Vendeville, A. Koul, Pierre Raboisson, & Nacer Lounis. (2015). CO-19 – JNJ-53718678: un composé actif contre le virus respiratoire syncitial. Archives de Pédiatrie. 22(5). 215–215. 1 indexed citations
6.
Rosenquist, Åsa, Bertil Samuelsson, Per-Ola Johansson, et al.. (2014). Discovery and Development of Simeprevir (TMC435), a HCV NS3/4A Protease Inhibitor. Journal of Medicinal Chemistry. 57(5). 1673–1693. 158 indexed citations
7.
Devogelaere, Benoit, Jan Martin Berke, Leen Vijgen, et al.. (2012). TMC647055, a Potent Nonnucleoside Hepatitis C Virus NS5B Polymerase Inhibitor with Cross-Genotypic Coverage. Antimicrobial Agents and Chemotherapy. 56(9). 4676–4684. 31 indexed citations
8.
Lenz, Oliver, Jan Martin Berke, Herman de Kock, et al.. (2010). 759 COMBINATION OF TMC435 WITH TWO NOVEL NS5B INHIBITORS INCREASES ANTI HCV ACTIVITY AND RESULTS IN A HIGHER GENETIC BARRIER IN VITRO. Journal of Hepatology. 52. S295–S296. 2 indexed citations
9.
Vandyck, Koen, Maxwell D. Cummings, Origène Nyanguile, et al.. (2009). Structure-Based Design of a Benzodiazepine Scaffold Yields a Potent Allosteric Inhibitor of Hepatitis C NS5B RNA Polymerase. Journal of Medicinal Chemistry. 52(14). 4099–4102. 50 indexed citations
10.
Raboisson, Pierre, Tse‐I Lin, Herman de Kock, et al.. (2008). Discovery of novel potent and selective dipeptide hepatitis C virus NS3/4A serine protease inhibitors. Bioorganic & Medicinal Chemistry Letters. 18(18). 5095–5100. 18 indexed citations
11.
Surleraux, Dominique, Geert Pille, Louis Maes, et al.. (2005). Design of HIV-1 Protease Inhibitors Active on Multidrug-Resistant Virus. Journal of Medicinal Chemistry. 48(6). 1965–1973. 59 indexed citations
12.
Vendeville, Sandrine. (2002). Comparison of the Inhibition of Human and Trypanosoma cruzi Prolyl Endopeptidases. Bioorganic & Medicinal Chemistry. 10(6). 1719–1729. 22 indexed citations
13.
Vendeville, Sandrine, Roger Joyeau, Izabela Marques Dourado Bastos, et al.. (2001). Trypanosoma cruzi Prolyl Oligopeptidase Tc80 Is Involved in Nonphagocytic Mammalian Cell Invasion by Trypomastigotes. Journal of Biological Chemistry. 276(50). 47078–47086. 97 indexed citations
14.
Charton, Julie, et al.. (2001). Convenient synthesis of tetrahydroisoquinoline-hydantoins. Tetrahedron Letters. 42(43). 7559–7561. 17 indexed citations
15.
Vendeville, Sandrine, Line Bourel‐Bonnet, Elisabeth Davioud–Charvet, et al.. (1999). Automated parallel synthesis of a tetrahydroisoquinolin-based library: Potential prolyl endopeptidase inhibitors. Bioorganic & Medicinal Chemistry Letters. 9(3). 437–442. 22 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026